newsfilter
← Latest News
GlobeNewswire·

ProQR Announces Third Quarter 2024 Operating and Financial Results

AX-0810 targeting NTCP for cholestatic diseases to be first ProQR Axiomer™ RNA editing program to enter the clinic Company to host virtual Investor and Analyst Event in December to highlight translational data and